The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis

Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor characterized by rapid progression, early metastasis, high recurrence, and limited responsiveness to conventional therapies. The 5-year survival rate of PDAC is extremely low (<8%), which lacks effective prognostic evaluation indicators...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bing, Zhou, Mingyao, Wu, Yunzi, Ma, Yuanyuan, Tan, Qin, Yuan, Wei, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580856/
https://www.ncbi.nlm.nih.gov/pubmed/34777388
http://dx.doi.org/10.3389/fimmu.2021.769047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580856/
https://www.ncbi.nlm.nih.gov/pubmed/34777388
http://dx.doi.org/10.3389/fimmu.2021.769047

Ejemplares similares